Company news

Pascal Biosciences Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Rob Gietl Joins Pascal Biosciences as New Chief Executive Officer

September 7, 2021

Hardy Forzley Joins Pascal Biosciences as Chief Financial Officer

June 16, 2021

InvestmentPitch Media Video Discusses Pascal Biosciences and its Award of a National Cancer Institute Grant for its Acute Lymphoblastic Leukemia Program - Video Available on Investmentpitch.com

June 9, 2021

Pascal Biosciences Awarded NIH Grant For Leukemia Program

June 8, 2021

Pascal Biosciences Announces New OTC Markets Trading Symbol PSCBF

May 31, 2021

Pascal Biosciences Announces Management Changes

March 22, 2021

Pascal Biosciences Inc. Closes Second Tranche of Non-Brokered Private Placement of $750,000

March 17, 2021

Pascal Biosciences to Present at Cannabinoid Derived Pharmaceuticals Industry Review Summit

January 21, 2021

Pascal Biosciences and S?RSE Technology Optimize Cannabinoid Formulation for Clinical Development of Cancer Treatment

December 8, 2020

Pascal Biosciences Appoints Mark van der Horst as Vice President of Corporate Communications

November 10, 2020

Pascal Biosciences Confirms Specific Cannabinoids Combat Coronavirus

September 23, 2020

Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceutical Summit

September 16, 2020

Pascal Biosciences and S?RSE Technology Announce Partnership for Cannabinoid Drug Development and Cancer Clinical Trials

September 14, 2020

Pascal Biosciences Announces Listing on the Frankfurt Stock Exchange

August 4, 2020

Pascal Biosciences Announces Feature Article

July 17, 2020

Pascal Biosciences Discovers a Cannabinoid That Combats Coronavirus

July 14, 2020

Pascal Biosciences Appoints Dr. Michael Shepard to Board of Directors

July 9, 2020